financetom
Business
financetom
/
Business
/
Kroger-Albertson's US anti-trust trial to end but other legal blocks loom
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Kroger-Albertson's US anti-trust trial to end but other legal blocks loom
Sep 17, 2024 3:26 AM

(Reuters) - The trial where U.S. anti-trust regulators made their case to block Kroger's ( KR ) $25 billion bid to buy rival grocer Albertsons ( ACI ) will conclude on Tuesday, but the deal's legal challenges have just begun, with two more trials this month to hear complaints the merger could jack up grocery bills.

For the past three weeks, the U.S. Federal Trade Commission and a coalition of states have sought to prove at trial in Portland, Oregon, that the deal would harm shoppers and unionized grocery workers.

By the time that case concludes on Tuesday, the companies will be on day two of another trial in Seattle where Washington state's attorney general is challenging the deal. Beginning on Sept. 30, a judge in Denver will hear Colorado's arguments for stopping the deal.

"It's a notable increase in the cost, stretches out the timeline, and is an unwelcome additional collection of obstacles" for the companies, said William Kovacic, an antitrust professor at George Washington University.

Kroger ( KR ) and Albertsons ( ACI ) have spent $864 million in merger costs this year, and they oppose all three cases. Kroger ( KR ) says the merger will result in lower prices and higher wages.

"Only global, non-unionized giants like Walmart ( WMT ), Amazon ( AMZN ) and Costco will benefit from this deal being blocked," the company said in a statement.

In Washington state, where Attorney General Bob Ferguson went to trial to block the deal on Monday, half of all grocery sales flow through one of the two chains, and 124 stores are slated to shift to C&S if the merger proceeds.

In addition to arguing the deal will raise prices and diminish choices for shoppers, Ferguson has argued it will make it easier for Kroger ( KR ) to close stores where workers are unionized and reopen them as non-union.

"We look forward to standing up for Washingtonians in Washington state court," Ferguson said in a statement.

Colorado, too, has sued to block the merger over concerns from shoppers, workers and local farmers who supply both chains.

"Colorado cares about having local food. And that is an area where these two companies compete against each other. It's important to farmers," Attorney General Phil Weiser said in a recent interview.

At the Oregon trial that began on Aug. 26, the FTC and a coalition of eight states plus Washington, D.C. called grocery executives, union leaders and economists as witnesses to try to show the deal is likely to drive up prices and diminish workers' bargaining power by eliminating head-to-head competition between the two chains.

The two grocers sought to show the deal was necessary to lower prices at Albertsons ( ACI ) stores and enable both chains to compete with Walmart ( WMT ).

Kroger ( KR ) has said no stores will be closed as a result of the merger. But that would not prevent stores being closed or consolidated down the road.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Rhythm Pharmaceuticals Insider Sold Shares Worth $608,498, According to a Recent SEC Filing
Rhythm Pharmaceuticals Insider Sold Shares Worth $608,498, According to a Recent SEC Filing
Mar 20, 2024
07:56 AM EDT, 03/20/2024 (MT Newswires) -- Pamela J. Cramer, Chief Human Resources Officer, on March 19, 2024, sold 15,515 shares in Rhythm Pharmaceuticals ( RYTM ) for $608,498. Following the Form 4 filing with the SEC, Cramer has control over a total of 30,005 shares of the company, with 30,005 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1649904/000110465924036310/xslF345X03/tm249308-1_4seq1.xml ...
Rhythm Pharmaceuticals Insider Sold Shares Worth $627,520, According to a Recent SEC Filing
Rhythm Pharmaceuticals Insider Sold Shares Worth $627,520, According to a Recent SEC Filing
Mar 20, 2024
08:00 AM EDT, 03/20/2024 (MT Newswires) -- Yann Mazabraud, EVP, Head of International, on March 19, 2024, sold 16,000 shares in Rhythm Pharmaceuticals ( RYTM ) for $627,520. Following the Form 4 filing with the SEC, Mazabraud has control over a total of 24,495 shares of the company, with 24,495 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1649904/000110465924036315/xslF345X03/tm249308-3_4seq1.xml ...
General Mills Fiscal Q3 Adjusted Earnings Increase, Net Sales Decline; Reaffirms Outlook, Shares Rise
General Mills Fiscal Q3 Adjusted Earnings Increase, Net Sales Decline; Reaffirms Outlook, Shares Rise
Mar 20, 2024
07:57 AM EDT, 03/20/2024 (MT Newswires) -- General Mills ( GIS ) reported fiscal Q3 adjusted earnings Wednesday of $1.17 per diluted share, up from $0.97 a year earlier. Analysts polled by Capital IQ expected $1.05. Net sales for the quarter ended Feb. 25 were $5.1 billion, down from $5.13 billion a year earlier. Analysts surveyed by Capital IQ expected...
Cheerios maker General Mills tops quarterly sales, profit estimates on higher prices
Cheerios maker General Mills tops quarterly sales, profit estimates on higher prices
Mar 20, 2024
March 20 (Reuters) - General Mills ( GIS ) topped market expectations for third-quarter sales and profit on Wednesday, backed by higher prices for its breakfast cereals, snack bars and pet food products that helped cushion a blow from slowing demand. Shares of the packaged food maker rose about 3% in premarket trading after it reaffirmed its annual sales and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved